Do Over-the-Counter Glucose Monitors Actually Improve Health? An Evidence Review

The era of prescription-only continuous glucose monitors (CGMs) has officially ended. Following the FDA's landmark clearances of the Dexcom Stelo and Abbott Lingo, a flood of over-the-counter biosensors has hit the consumer market.[8]

Originally designed to prevent life-threatening hypoglycemic events in insulin-dependent diabetics, these quarter-sized wearables are now being marketed directly to the wellness crowd.[1][2]

The pitch is compelling: stick a sensor to the back of your arm, pair it with a smartphone via Bluetooth, and watch in real time as your body reacts to a bowl of oatmeal, a stressful meeting, or a brisk walk.[2][4]

But as these devices transition from medical necessities to consumer shopping cart staples, a critical question emerges: does the scientific evidence support their use for people who do not have diabetes?[1][7]

To understand the evidence, it is essential to understand what these devices actually measure. Over-the-counter CGMs do not measure blood glucose directly. Instead, a tiny filament sits just beneath the skin, measuring glucose levels in the interstitial fluid—the fluid between cells.[4][7]

Because glucose takes time to travel from the bloodstream into the interstitial fluid, there is an inherent delay. Readings typically trail actual blood glucose by five to fifteen minutes, a lag that becomes most apparent during rapid changes like intense exercise.[7]

Despite this lag, the accuracy of modern over-the-counter sensors is robust. Clinical evaluations published in peer-reviewed journals like Diabetes Technology & Therapeutics indicate that these devices maintain a Mean Absolute Relative Difference (MARD)—the standard metric for CGM accuracy—of under 10 percent.[5]

For a non-diabetic user, an 8.8 percent MARD is more than sufficient to identify broad physiological trends, such as whether a specific meal causes a massive spike or a gentle rolling hill.[5][7]

The primary argument for consumer CGMs is behavioral modification. Proponents argue that seeing a sharp glucose spike after eating a pastry provides immediate, personalized feedback that a generic nutrition label simply cannot match.[2][4]

Early observational data suggests this feedback loop can be highly effective. Users frequently report reducing their intake of refined carbohydrates and increasing their post-meal physical activity—such as taking a ten-minute walk—to blunt glucose spikes.[2][4]

The landmark Diabetes Prevention Program trial established decades ago that lifestyle interventions, including diet and moderate exercise, are highly effective at preventing the onset of type 2 diabetes in high-risk populations.[6]

If wearing a continuous glucose monitor successfully nudges a user toward those proven lifestyle changes, the downstream metabolic benefits could be substantial, even if the device itself is merely an observational tool.[6][7]

However, clinical skeptics point out a glaring gap in the literature: there are currently no large-scale randomized controlled trials proving that CGM use in healthy adults leads to sustained weight loss or a lower incidence of metabolic disease.[1][7]

Medical professionals warn that more data does not automatically equal better health. In some cases, the hyper-visibility of normal physiological processes can trigger unnecessary anxiety and confusion.[1][2]

It is entirely normal for a healthy body's glucose levels to rise after a meal and subsequently fall as insulin efficiently does its job.[1][2]

Some users, misinterpreting these natural spikes as inherently harmful, may unnecessarily restrict healthy foods like fruits or complex carbohydrates, potentially leading to disordered eating patterns.[1][2]

Despite these concerns, the regulatory landscape continues to broaden. In June 2026, the FDA expanded the clearance for the Dexcom Stelo to include children aged two and older who do not use insulin.[3][8]

This pediatric clearance aims to address the rising rates of childhood prediabetes, offering parents a tool to monitor how family meals and activities impact their children's metabolic health, provided it is used under adult supervision.[3]

Ultimately, the utility of an over-the-counter CGM depends heavily on the user's mindset. At an estimated cost of $100 to $150 per month without insurance coverage, they represent a premium wellness investment.[7]

For those who treat the data as a gentle guide to optimize their daily habits, devices like the Lingo and Stelo offer unprecedented metabolic visibility. But for those prone to health anxiety, the constant stream of numbers may prove more stressful than helpful.[1][2][7]